Rapid Tests - Global Strategic Business Report 2026: Capitalize On $4.2 Billion In Market Expansion By 2032 With SGS, Eurofins Scientific, Bureau Veritas And Intertek


Date:

(MENAFN- GlobeNewsWire - Nasdaq) Dublin, Nov. 19, 2026 (GLOBE NEWSWIRE) -- "Rapid Tests - Global Strategic Business Report 2026" has been added to ResearchAndMarkets.com's offering.

The global rapid tests market was valued at US$12.4 billion in 2025 and is projected to reach US$16.6 billion by 2032, advancing at a compound annual growth rate (CAGR) of 4.3%. Market expansion is supported by rising demand for timely diagnostic results, continued innovation in molecular diagnostics and immunoassays, and the growing adoption of decentralized healthcare services.

Rapid Tests Market Trends and Growth Drivers

Rapid diagnostic tests are increasingly important across clinical care, disease screening, emergency medicine, and chronic disease management. They support the detection of infectious diseases such as COVID-19, influenza, HIV, malaria, hepatitis, and sexually transmitted infections. Rapid tests are also used to assess cardiac biomarkers, monitor blood glucose, identify sepsis, and support the management of other acute and chronic conditions.

The increasing prevalence of infectious diseases remains a major rapid tests market growth driver. Healthcare providers, public health agencies, laboratories, and community-based organizations require diagnostic solutions that support early detection, timely treatment, and effective infection-control measures. Expanding screening programs and greater investment in preventive healthcare are also increasing demand across developed and emerging markets.

Technological developments are improving the sensitivity, specificity, portability, and connectivity of rapid testing platforms. PCR-based rapid tests, advanced immunoassays, miniaturized diagnostic systems, and digitally connected point-of-care devices are extending testing beyond centralized laboratories. Clinics, pharmacies, emergency departments, community health facilities, and home-care environments are consequently becoming important adoption settings.

Demand is also being strengthened by the shift toward patient-centered and decentralized care. Rapid tests can streamline clinical workflows, reduce turnaround times, and provide actionable data at or near the point of care. These capabilities are particularly valuable in remote and resource-constrained locations where access to centralized laboratory infrastructure may be limited.

Market Segment and Regional Outlook

The report analyzes the global rapid tests market by offering, technology, application, end use, and geography. Offerings include instruments, consumables, and other products. Technology coverage includes immunoassays, molecular diagnostics, and additional testing technologies.

Applications encompass respiratory tract infections, sexually transmitted infections, antibiotic-resistant infections, gastrointestinal infections, sepsis, tropical and vector-borne diseases, and other diagnostic areas. End-use markets include hospitals and clinics, laboratories, and other healthcare settings.

  • The instruments segment is forecast to reach US$6.4 billion by 2032, expanding at a CAGR of 3.6%.
  • The consumables segment is projected to grow at a CAGR of 4.3% during the analysis period.
  • The U.S. rapid tests market was valued at approximately US$3.4 billion in 2025.
  • China is expected to record a CAGR of 7.3% and reach US$3.4 billion by 2032.
  • The geographic analysis also covers Canada, Japan, Germany, the wider European market, Asia-Pacific, Latin America, the Middle East, and Africa.

Report Scope and Strategic Value

The rapid tests market report provides independent annual sales analysis and forecasts from 2025 through 2032, presented in US$ million. It examines market trends, competitive conditions, regional opportunities, technology developments, and the factors influencing demand across major applications and end-use sectors.

Organizations can use the research to evaluate growth opportunities, compare regional market dynamics, assess high-potential segments, and support product development, investment, partnership, and market-entry decisions. The report also addresses how the global rapid tests market is expected to evolve through 2032, which segments may achieve the strongest growth, and how competitive positions could change across key geographies.

Competitive Landscape

The report includes company intelligence and competitive analysis for selected organizations participating in the rapid tests market. Featured companies include:

  • ALS Ltd.
  • AsureQuality Ltd.
  • Bureau Veritas SA
  • Eurofins Scientific SE
  • Genetic ID NA, Inc.
  • Intertek Group PLC
  • Merieux NutriSciences Corporation
  • Microbac Laboratories, Inc.
  • Omic USA Inc.
  • Romer Labs, Inc.
  • SGS SA
  • TUV SUD AG

Domain Expert Insights

The research incorporates perspectives from industry specialists, enterprise leaders, and academic experts to provide context beyond conventional secondary research. The report tracks early market signals emerging from expert discussions, company activity, conference sessions, keynote presentations, panel discussions, corporate disclosures, annual reports, institutional publications, and other validated sources.

These insights connect emerging signals with strategic market direction, helping identify the technologies, business models, regional developments, and competitive actions likely to influence future growth. Company-level intelligence extends the analysis beyond overall market performance to examine organizations shaping the competitive environment.

Market share is assessed where it provides meaningful strategic value. Because competitive structures differ by geography, the report evaluates major regional markets according to their individual characteristics rather than relying solely on a single global market share measure. Complimentary updates for one year provide continued access to relevant market developments.

Key Attributes

Report Attribute Details
No. of Pages 479
Forecast Period 2025-2032
Estimated Market Value (USD) in 2025 $12.4 Billion
Forecasted Market Value (USD) by 2032 $16.6 Billion
Compound Annual Growth Rate 4.3%
Regions Covered Global


For more information about this report visit

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

MENAFN19112026004107003653ID1111990850


GlobeNewsWire - Nasdaq

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.



More Story

Search